You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

340 Results
Drug
Other Name(s): Proleukin® (interleukin-2)
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2024
Drug
Other Name(s): MabCampath®
Quick Link(s): Drug Monograph, Patient Info Sheet
Sep 2019
Drug
Other Name(s): Tasigna®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jul 2025
Drug
Other Name(s): Abraxane®
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 2024
Drug
Other Name(s): Zytiga®
Quick Link(s): Drug Monograph, Patient Info Sheet
Aug 2024
Drug
Other Name(s): Inlyta®
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2024
Drug
Other Name(s): Trisenox®
Quick Link(s): Drug Monograph, Patient Info Sheet
Oct 2025
Drug
Other Name(s): Giotrif®
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2024
Drug
Other Name(s): Atriance®
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2024
Drug
Other Name(s): Agrylin®
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2024
Regimen
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative, Curative
Funding:
New Drug Funding Program
    Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
aldesleukin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2019
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
alemtuzumab (Compassionate)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2019

Pages